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Tiivistelmä:  
Biometalleilla on merkittävä rooli solujen ja kudosten toiminnassa. Ne ovat monen 
entsyymin toiminnassa elintärkeitä, mutta toisaalta solut pyrkivät pitämään niiden 
pitoisuudet tarkoissa rajoissa. Metallin yli- tai alimäärä voi joko itsessään vaikeuttaa 
solujen normaalia toimintaa tai olla merkki epätavallisesta metaboliasta. Fragile X-
oireyhtymä on monogeeninen kehitysvammaisuutta aiheuttava perinnällinen sairaus, joka 
johtuu FMRP-proteiinin puutoksesta. Oireyhtymä on mahdollisesti yleisin periytyvän 
autismin syy.  
23 metallin kudospitoisuudet mitattiin Fragile X-oireyhtymää mallintavan hiirimallin ja 
kontrollihiirten pikkuaivoista, isoaivokuorelta, maksasta, sydämestä ja pernasta 
induktiivisesti kytketty plasma -massaspektrometrillä. Seitsemän metallin – Cu, Fe, K, 
Mg, Mn, Na ja P – pitoisuudet olivat mittausrajan yläpuolella.  
Hiirimallin sydämen ja pikkuaivojen rautapitoisuudet olivat korkeampia kuin 
kontrollihiirten vastaavista kudoksista mitatut arvot. Löydösten merkitsevyydet olivat 
kuitenkin statistisesti raja-arvoisia. PCA-analyysi vahvisti käsitystä muuttuneesta 
metallihomeostaasista hiirimallin sydämessä, ja toisaalta Fragile X-oireyhtymän 
aiheuttavan FMRP-proteiinin mutaatiot on aiemmin liitetty ihmisillä pikkuaivojen 
rautakertymiin.  
Tutkimus kärsii pienen näytemäärän takia alhaisesta voimasta, mutta rautamuutokset 
sopivat aiemmin kuvattuun FMRP-proteiiniin liitettyyn inflammaatioon. Tässä 
tutkimuksessa sekä aiemmissa julkaisuissa kuvattu biometallien epätasapaino edellyttää 
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Trace elements have important functions in several processes involved in cellular 
homeostasis and survival. Dysfunctional metal ion homeostasis can make an important 
impact on cellular defence mechanisms. We assessed the concentrations of 23 trace 
minerals in different tissues (brain, spleen, heart and liver) of Fmr1 knockout (KO) mice 
that display the main phenotype of Fragile X syndrome (FXS), an intellectual disability 
syndrome and the best-known monogenic model of autism spectrum disorder (ASD). 
Altogether, seven minerals – Cu, Fe, K, Mg, Mn, Na, and P – were above the detection 
limit with the analysis revealing increased iron content in the heart of Fmr1 KO mice. In 
addition, levels of iron were higher in the cerebellum of the transgenic mouse when 
compared to wild type controls. These results implicate a role for dysregulated iron 
homeostasis in FXS tissues and suggest that defective iron-related mechanisms contribute 





































Fragile X syndrome (FXS) is an intellectual disability syndrome with a prevalence of 
around 1/4000 in males and 1/6000-8000 in females (Crawford et al. 1999). The FXS 
neurobehavioral phenotype includes abnormalities in speech development and 
communication, social behaviour, sensory reactivity, attention, arousal, and activity 
levels (Hagerman et al. 2010). The vast majority of FXS males display some behaviours 
characteristic of individuals with autism spectrum disorder (ASD) with some (~10-30%) 
fulfilling the standardised criteria for ASD (Brown et al. 1986). FXS is a monogenic 
disorder caused by the absence of FMR1 protein (FMRP) and the Fmr1 knockout (KO) 
mouse recapitulates the human FXS phenotype.  In most FXS patients, a CGG triple 
repeat expansion comprising > 200 repeats leads to transcriptional silencing of the FMR1 
gene (O’Donnell and Warren 2002). The length of the repeated CGG sequence of the 
FMR1 gene in the range of 6-44 repeats is normal, whereas 45-54 repeats is intermediate 
or grey area, and 55 to 200 repeats is considered as premutation (Verkerk et al. 1991; 
Penagarikano et al. 2007). The premutation causes increased FMR1 mRNA levels that 
associates with slightly reduced FMRP expression and does not result in any 
neurodevelopmental syndrome, but can lead to the onset of Fragile X-associated 
Tremor/Ataxia Syndrome (FXTAS) after the age of 50 years (Loesch and Hagerman 
2012). 
 
An inappropriate intake or absorption of trace elements is associated with a variety of 
health problems. Altered metal homeostasis is linked to a number of disorders and heavy 
metal exposure is presented as a potential risk factor for neurodevelopmental disorders 
(Froehlich et al. 2011; Scassellati et al. 2012; Kanninen et al. 2013). It has been suggested 
that metal deficiency and/or toxic metal burdens may epigenetically contribute to the 
manifestation of ASD (Yasuda et al. 2013). However, several studies searching changes 
of trace elements/metals in ASD have generated inconsistent results with high individual 
variation in levels of minerals (Saghazadeh et al. 2017; Tseng et al. 2018; Curtin et al. 
2018; Austin et al. 2019; Hassan et al. 2019). Studies of genetic mouse models of 
neurodevelopmental diseases could provide important additional information about the 
relationship of trace metal balance and ASD. 
 
Metal ions are tightly linked to the redox state of a cell. Oxidative stress is elevated in the 
brain of Fmr1 KO mice (El Bekay et al. 2007), but tissue trace element homeostasis has 
not been previously examined in FXS. We investigated biometal concentrations in 
different tissues of the Fmr1 KO mice. Using sensitive inductively coupled plasma mass 
spectrometry (ICP-MS) to analyse trace elements, seven minerals were reliably detected 






Fmr1 KO mice (B6.129P2-Fmr1tm1/Cgr/J, Jackson Laboratory, Bar Harbor, ME) and 
their wild type (WT) littermates were used at the age of 4-5 months. Genotyping by tail-
PCR was performed as previously described (The Dutch-Belgian Fragile X Consorthium 
et al. 1994). Mice were housed in groups and subjected to a 12-hour light-dark cycle with 
access to food and water ad libitum. All animal experiments were done in accordance 
with the guidelines of the National Institute of Health Guide for the Care and Use of 
Laboratory Animals and carried out using protocols approved by the Experimental 
Animal Ethical Committee of Southern Finland.  
 
2.2. Mouse tissues 
For tissue collection, mice were anaesthetised with carbon dioxide and sacrificed by 
cervical dislocation. Brains, spleens, hearts, and livers were collected. Cerebellums and 
the ventral regions of the cerebral cortex were further dissected. The tissue pieces were 
weighed. There were no differences of average wet weights (P < 0.05) between control 
and FXS tissue samples (Table 1). All tissues were snap frozen and stored at -80°C until 
use. 
 
2.3 Mass-spectrometry analysis 
The tissue concentrations of trace elements were measured by an established and fully 
validated method using ICP-MS as described previously (Maynard et al. 2002; Kanninen 
et al. 2013). Due to technical problems, four samples were not processed (Fmr1 KO 
cortex, WT liver and both Fmr1 KO and WT cerebellum). Briefly, weighed tissue 
samples were lyophilised, digested in 100–300 µl of 65% nitric acid (Merck, Kilsyth, 
Victoria, Australia) overnight at room temperature (RT), and heated for 20 min at 90°C. 
Then an equivalent volume of 30% hydrogen peroxide (30% Aristar,  BDH) was added 
and samples were incubated for 30 min at RT, followed by 15 min at 70°C. The average 
reduced volume was determined, and the samples were diluted with 1% nitric acid diluent 
using dilution factors as shown in Table 1. Volume of digest was the amount of the 
digested sample that was used to make the dilution. 
 
Table 1 Sample preparation Sample weights are mean ± SEM. 
 
Measurements were made with an Agilent 7700 series ICP-MS instrument (Agilent 
Technologies, Santa Clara, CA, USA) under routine multi-element operating conditions 
using helium as cell gas. The instrument was calibrated using 0, 5, 10, 50, and 100 ppb 
of certified multi-element standard calibration solutions (ICP-MS-CAL2-1, ICP-MS-
CAL-3, and ICP-MS-CAL-4; Accustandard, New Haven, CT, USA) for the range of the 
elements and 200 ppb of Yttrium (Y89) was used as internal control (ICP-MS-IS-MIX1-
1, Accustandard). Three media blanks were used to determine detection limits. 
Conversion of readings in ppb was performed as follows: (ug/g) = (raw ppb value x 
dilution factor x reduced digest volume)/(tissue wet weight g). Samples were analysed in 
triplicate and median values were used for analyses. Results are expressed in micrograms 
of metal per gram of wet (µg/g wet wt). The concentration of 23 minerals and trace 
elements were assessed in mouse heart, liver, spleen, and brain tissues. Altogether, 7 trace 
elements (Cu, Fe, K, Mg, Mn, Na, and P) were above detection limits in our set of samples 
(Table 2), whereas 16 trace elements (Al, B, Ba, Ca, Cd, Co, Cr, Li, Mo,  





























Cerebellum 12 63 ± 5.9 52 ± 8 100 150 21 50 
Cortex 12 140 ± 5.2 140 ± 11 100 135 21 50 
Heart 14 82 ± 8 59 ± 7 150 210 21 50 
Liver 12 170 ± 20 160 ± 17 300 470 51 30 
Spleen  13 56 ± 6.9 70 ± 4.4 150 210 21 50 
Table 2 The absolute metal content in the set of WT tissue samples of average size 
and concentrations of the medium and acid blanks  
 
2.4 Statistical analysis 
Statistical significance between KO and WT mouse tissues with each variable was 
determined with the Student´s t-test. The principal component analysis (PCA) was 
performed with all 35 metal variables (7 elements in 5 tissues). In the analysis, two WT 
mice were excluded due to several missing values and the missing values were replaced 
with the means when maximum of two tissues were missing. All statistical analyses, 
including linear correlations across all variables, were carried out using IBM SSPS 
Statistics. Data are shown as mean ± standard deviation. The criterion for significance 
was set to P < 0.05. 
 
3. Results  
 
Mean metal concentrations of WT and KO mouse tissues are presented in Table 3. Most 
significantly, iron was increased in the hearts (p = 0.033) of the KO mice (Fig.1). The 
highest iron content was seen in spleen and the levels were relatively low in the brain 
tissues. An increase in iron content in the cerebellum of the Fmr1 KO was found at the 
marginal level of significance (p = 0.052). The methodology suffered from low power 
and these statistical significances should be considered in the context of 35 individual 
comparisons (7 metals in 5 tissues) between KO and WT mice (Bonferroni correction for 
a typical α = 0.05 with 35 comparisons p < 0.0014, and the family-wise error rate for 35 
comparisons at α = 0.05 was 0.83). 
 






Na (μg) 210 96 130 38 98 25 32 
Mg 
(μg) 14 7.5 36 9.2 14 
0.69 0.31 
P ( g) 330 190 530 180 170 4.2 2.5 
K (μg) 330 160 500 180 160 4.1 5.4 
Mn 
(ng) 29 21 120 8.2 31 
0.013 0 
Fe (ng) 910 540 12000 26000 3500 0.29 0 
Cu (ng) 300 200 720 36 360 0.076 0.0016 
Table 3 Concentrations of different metals in heart, spleen, liver, cerebellum, and 
cortex of Fmr1 KO mice compared to WT controls  











Cortex Cerebellum Liver Spleen Heart 
Na 
(μg/g) 






1900 ± 330 730 ± 73 590 ± 160 1400 ± 
380  
p 0.83 0.21 0.39 0.41 0.19 
Mg 
(μg/g) 




95 ± 18 140 ± 38 210 ± 31 150 ± 34 210 ± 48 
 
p 0.61 0.4 0.8 0.51 0.16 
P ( μ g/g) WT 2300 ± 
280 
















p 0.82 0.41 0.5 0.55 0.23 
K (μg/g) WT 2400 ± 
300 
















p 0.67 0.35 0.53 0.49 0.069 
Mn 
(μg/g) 
WT 0.21 ± 
0.014 
















p 0.39 0.69 0.14 0.69 0.11 
Fe (μg/g) WT 6.6 ± 0.91 8.6 ± 2.6 70 ± 15 460 ± 200 43 ± 11  
Fmr1 
KO 
7.6 ± 1.5 13 ± 2.8 66 ± 19 510 ± 190 62 ± 17 
 
p 0.18 0.052 0.74 0.7 0.033 * 
Cu 
(μg/g) 
WT 2.2 ± 0.27 3.2 ± 1.7 4.2 ± 0.93 0.64 ± 
0.21 




2 ± 0.44 4.4 ± 1.1 4.2 ± 1.2 0.55 ± 
0.13 
5.5 ± 1.4 
 
p 0.39 0.31 0.96 0.44 0.16 
Fig.1 Concentration of iron across tissues. Values for individual Fmr1 KO and WT 
mice are plotted. 
 
 
To evaluate the complete dataset for pattern of variations, we used the PCA. Three 
components were extracted, explaining a total of 73% of the total variance; PC1 explained 
35%, PC2 23%, and PC3 15%. PC1 correlated closely with brain and spleen variables. 
PC2 correlated with heart variables and PC3 was influenced mostly by liver variables. T-
tests with respect to the genotype on each extracted principal component showed that KO 
and WT mice segregated across PC2 (p = 0.031), but not across PC1 (p = 0.9) or PC3 (p 
= 0.99), implicating altered biometal homeostasis in the heart of the Fmr1 KO mouse. 






Fig.2 Principal component analysis (PCA) that was used to classify Fmr1 KO and 
WT mice based on metal content of seven different metals in five tissues is shown 
with respect to PC1 and PC2. KO and WT mice segregated across PC2 (p = 0.031) 
that explained 35% of the total variance and correlated with heart 
variables. Variables are coded by colour with respect to tissue studied. 
 
Brain and liver metal levels measured in the present study were comparable to previously 
reported measurements in mouse and rat tissues (SATO et al. 1996; Schneider et al. 2014; 
Garza-Lombó et al. 2018). In our analysis, within a tissue, metal concentrations generally 
correlated positively, but negatively with the mass of the tissue sample. Furthermore, we 
observed that Mg correlated strongly (r > 0.95) with P and K in most tissues, whereas Cu 
correlated strongly with P, Mg and K in spleens and hearts. A correlation matrix is 
provided in Online Resource 1. 
 
4. Discussion  
  
The present study demonstrated elevations of iron levels in heart and cerebellum of the 
Fmr1 KO mouse. Iron is a redox-active metal and an essential component of many 
proteins involved in biological defence mechanisms against oxidative stress (Crichton 
and Pierre 2001). A moderate increase in stress status has been previously reported in the 
adult Fmr1 KO mouse brain, reflecting a deficient antioxidant system together with 
higher levels of reactive oxygen species, nicotinamide adenine dinucleotide phosphate 
(NADPH) -oxidase activation, lipid peroxidation and protein oxidation (El Bekay et al. 
2007). Furthermore, studies of human FMR1 premutation fibroblasts have revealed 
mitochondrial chain dysfunction and abnormally increased reactive oxygen species 
(ROS) production, which responded to chelation of iron with desferrioxamine mesylate 
(DFO) (Napoli et al. 2011). Since the FMR1 premutation alters FMR1 transcript 
expression and slightly reduces FMRP levels, the findings are consistent with 
involvement of FMRP in the regulation of iron balance. 
 
FMRP has previously been implicated in protective mechanisms against injury in heart 
(Bao et al. 2018). Overexpression of FMRP was found to alleviate oxidative stress and 
apoptosis in damaged cardiomyocytes. Many FXS patients suffer from dilatation of aortic 
root and mitral valve prolapse that have been linked to connective tissue dysplasia. There 
is also evidence that sympathetic activity augments cardiac activity and output in FXS 
more than in healthy controls (Sreeram et al. 1989). A 1.4-fold increase in iron content in 
the heart tissue of Fmr1 KO mouse provides evidence of pathological cellular processes, 
but its impact on heart function remains to be investigated. The extent of iron toxicity 
depends on localisation of the iron complex within the cell e.g. cytosolic vs. lysosomal, 
its biochemical form, and the cellular content of a wide range of antioxidants and 
cytoprotective enzymes that can prevent the generation and propagation of free radical 
species. Mitochondrial iron accumulation in cardiac tissue and brain is associated with 
Friedrich ataxia (FRDA). The excess iron exists as highly localized multifocal aggregates 
rather than a diffuse pattern in the tissue of FRDA patients and iron-mediated toxicity is 
not well understood (Llorens et al. 2019).  
 
Region-specific accumulation of iron can particularly contribute to the pathophysiology 
of brain diseases due to the decreased ability of neuronal cells to respond to oxidative 
stress. Increased iron levels have been linked to abnormalities of cerebellar myelination 
(Beltrán-Navarro et al. 2012; Klocke et al. 2018; Fernández et al. 2019). Accumulation 
of iron in the cerebellum of the Fmr1 KO mice is especially interesting considering the 
cerebellar changes and altered firing rate of neurons in cerebellar circuitry of Fmr1 KO 
mice. Cerebellar vermis is essential in gating of sensorimotor reactions (Leaton and 
Supple 1986), and impaired acoustic startle reflex in human and mouse models of FXS 
also supports involvement of cerebellar defects in FXS. Cerebellum was not studied as a 
separate brain region in the oxidative stress study of Fmr1 KO mice by el Bekay et al. 
(2007). Mild cerebellar accumulation of iron was previously shown in a subset of FMR1 
premutation carriers with FXTAS (Rogers et al. 2016), who display defective iron and 
zinc metabolism (Napoli et al. 2011).  
 
Biometal supplements are used without medical prescription and are often tested as 
treatment of neurodevelopmental disorders when no other treatment is available. Current 
research data do not provide sufficient information to formulate recommendations for use 
of trace elements/metals (Lyall et al. 2014; Devilbiss et al. 2017). Iron is important for 
normal behavioural development and its deficiency is often seen in ASD patients (Latif 
et al. 2002). However, altered iron levels in ASD may be primarily of environmental 
origin and not directly linked to ASD (Reynolds et al. 2012). Mouse models offer 
possibilities to investigate disease-related biometal homeostasis and to evaluate the 
effectiveness of treatments. It is important to note that accumulation of trace elements 
may increase the risk of tissue damage. Our observation that heart iron content was 
increased in the FXS mouse may have clinical impact, because increased cardiac iron 
levels can lead to iron overload cardiomyopathy, a potentially lethal condition. 
Furthermore, our study suggests that brain region-specific alterations of iron exist in FXS. 
Altogether, the present findings showing accumulation of iron in distinct Fmr1 KO mouse 
tissues are fundamental and promote further research to evaluate role of biometals in FXS 








Karo Talvio: Data curation, Visualisation, Original draft preparation; Katja Kanninen: 
Methodology, Data collection; Anthony White: Supervision, Methodology; Maija 







Austin C, Curtin P, Curtin A, et al (2019) Dynamical properties of elemental metabolism 
distinguish attention deficit hyperactivity disorder from autism spectrum disorder. 
Transl Psychiatry. https://doi.org/10.1038/s41398-019-0567-6 
Bao J, Ye C, Zheng Z, Zhou Z (2018) Fmr1 protects cardiomyocytes against 
lipopolysaccharide‑induced myocardial injury. Exp Ther Med. 
https://doi.org/10.3892/etm.2018.6386 
Beltrán-Navarro B, Matute E, Vásquez-Garibay E, Zarabozo D (2012) Effect of chronic 
iron deficiency on neuropsychological domains in infants. J Child Neurol. 
https://doi.org/10.1177/0883073811416867 
Brown WT, Jenkins EC, Cohen IL, et al (1986) Fragile X and autism: A multicenter 
survey. Am. J. Med. Genet. 
Crawford DC, Meadows KL, Newman JL, et al (1999) Prevalence and phenotype 
consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special 
education - needs population. Am J Hum Genet. https://doi.org/10.1086/302260 
Crichton RR, Pierre JL (2001) Old iron, young copper: from Mars to Venus. Biometals 
14:99–112. https://doi.org/10.1023/a:1016710810701 
Curtin P, Austin C, Curtin A, et al (2018) Dynamical features in fetal and postnatal zinc-
copper metabolic cycles predict the emergence of autism spectrum disorder. Sci Adv 
4:eaat1293. https://doi.org/10.1126/sciadv.aat1293 
Devilbiss EA, Magnusson C, Gardner RM, et al (2017) Antenatal nutritional 
supplementation and autism spectrum disorders in the Stockholm youth cohort: 
Population based cohort study. BMJ. https://doi.org/10.1136/bmj.j4273 
El Bekay R, Romero-Zerbo Y, Decara J, et al (2007) Enhanced markers of oxidative 
stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X 
mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. 
Eur J Neurosci. https://doi.org/10.1111/j.1460-9568.2007.05939.x 
Fernández M, Sierra-Arregui T, Peñagarikano O (2019) The Cerebellum and Autism: 
More than Motor Control. In: Behavioral Neuroscience [Working Title] 
Froehlich TE, Anixt JS, Loe IM, et al (2011) Update on Environmental Risk Factors for 
Attention-Deficit/Hyperactivity Disorder. Curr Psychiatry Rep 13:333–344. 
https://doi.org/10.1007/s11920-011-0221-3 
Garza-Lombó C, Posadas Y, Quintanar L, et al (2018) Neurotoxicity Linked to 
Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox 
Signaling and Oxidative Stress. Antioxid Redox Signal 28:1669–1703. 
https://doi.org/10.1089/ars.2017.7272 
Hagerman R, Hoem G, Hagerman P (2010) Fragile X and autism: Intertwined at the 
molecular level leading to targeted treatments. Mol. Autism 
Hassan MH, Desoky T, Sakhr HM, et al (2019) Possible Metabolic Alterations among 
Autistic Male Children: Clinical and Biochemical Approaches. J Mol Neurosci 
67:204–216. https://doi.org/10.1007/s12031-018-1225-9 
Kanninen KM, Grubman A, Meyerowitz J, et al (2013) Increased Zinc and Manganese in 
Parallel with Neurodegeneration, Synaptic Protein Changes and Activation of 
Akt/GSK3 Signaling in Ovine CLN6 Neuronal Ceroid Lipofuscinosis. PLoS One 
8:e58644. https://doi.org/10.1371/journal.pone.0058644 
Klocke C, Sherina V, Graham UM, et al (2018) Enhanced cerebellar myelination with 
concomitant iron elevation and ultrastructural irregularities following prenatal 
exposure to ambient particulate matter in the mouse. Inhal Toxicol. 
https://doi.org/10.1080/08958378.2018.1533053 
Latif A, Heinz P, Cook R (2002) Iron Deficiency in Autism and Asperger Syndrome. 
Autism 6:103–114. https://doi.org/10.1177/1362361302006001008 
Leaton R, Supple W (1986) Cerebellar vermis: essential for long-term habituation of the 
acoustic startle response. Science (80- ). https://doi.org/10.1126/science.3961494 
Llorens JV, Soriano S, Calap-Quintana P, et al (2019) The Role of Iron in Friedreich’s 
Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models. 
Front Neurosci 13:. https://doi.org/10.3389/fnins.2019.00075 
Loesch D, Hagerman R (2012) Unstable Mutations in the FMR1 Gene and the 
Phenotypes. pp 78–114 
Lyall K, Schmidt RJ, Hertz-Picciotto I (2014) Maternal lifestyle and environmental risk 
factors for autism spectrum disorders. Int J Epidemiol. 
https://doi.org/10.1093/ije/dyt282 
Maynard CJ, Cappai R, Volitakis I, et al (2002) Overexpression of Alzheimer’s disease 
amyloid-β opposes the age-dependent elevations of brain copper and iron. J Biol 
Chem. https://doi.org/10.1074/jbc.M204379200 
Napoli E, Ross-Inta C, Wong S, et al (2011) Altered zinc transport disrupts mitochondrial 
protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol 
Genet. https://doi.org/10.1093/hmg/ddr211 
O’Donnell WT, Warren ST (2002) A Decade of Molecular Studies of Fragile X 
Syndrome. Annu Rev Neurosci. 
https://doi.org/10.1146/annurev.neuro.25.112701.142909 
Penagarikano O, Mulle JG, Warren ST (2007) The pathophysiology of fragile x 
syndrome. Annu Rev Genomics Hum Genet 8:109–29. 
https://doi.org/10.1146/annurev.genom.8.080706.092249 
Reynolds A, Krebs NF, Stewart PA, et al (2012) Iron status in children with autism 
spectrum disorder. Pediatrics. https://doi.org/10.1542/peds.2012-0900M 
Rogers H, Ariza J, Monterrubio A, et al (2016) Cerebellar Mild Iron Accumulation in a 
Subset of FMR1 Premutation Carriers with FXTAS. The Cerebellum 15:641–644. 
https://doi.org/10.1007/s12311-016-0798-5 
Saghazadeh A, Ahangari N, Hendi K, et al (2017) Status of essential elements in autism 
spectrum disorder: Systematic review and meta-analysis. Rev. Neurosci. 
SATO H, TAKAHASHI S, SUZUKI K, et al (1996) Change in the Concentrations of 
Metal Elements in Various Organs of the Mouse following Multiple Intraperitoneal 
Administration of Ca-DTPA. Japanese J Heal Phys 31:41–48. 
https://doi.org/10.5453/jhps.31.41 
Scassellati C, Bonvicini C, Faraone S V., Gennarelli M (2012) Biomarkers and Attention-
Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analyses. J Am 
Acad Child Adolesc Psychiatry 51:1003-1019.e20. 
https://doi.org/10.1016/j.jaac.2012.08.015 
Schneider SN, Liu Z, Wang B, et al (2014) Oral Cadmium in Mice Carrying 5 Versus 2 
Copies of the Slc39a8 Gene. Int J Toxicol 33:14–20. 
https://doi.org/10.1177/1091581813513530 
Sreeram N, Wren C, Bhate M, et al (1989) Cardiac abnormalities in the fragile X 
syndrome. Heart 61:289–291. https://doi.org/10.1136/hrt.61.3.289 
The Dutch-Belgian Fragile X Consorthium, Bakker CE, Verheij C, et al (1994) Fmr1 
knockout mice: A model to study fragile X mental retardation. Cell. 
https://doi.org/10.1016/0092-8674(94)90569-X 
Tseng PT, Cheng YS, Chen YW, et al (2018) Peripheral iron levels in children with 
autism spectrum disorders vs controls: a systematic review and meta-analysis. Nutr 
Res. https://doi.org/10.1016/j.nutres.2017.11.004 
Verkerk AJMH, Pieretti M, Sutcliffe JS, et al (1991) Identification of a gene (FMR-1) 
containing a CGG repeat coincident with a breakpoint cluster region exhibiting 
length variation in fragile X syndrome. Cell 65:905–914. 
https://doi.org/10.1016/0092-8674(91)90397-H 
Yasuda H, Yasuda Y, Tsutsui T (2013) Estimation of autistic children by metallomics 
analysis. Sci Rep 3:1199. https://doi.org/10.1038/srep01199 
 
 
 
